(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as substituted anilino halobenzamide (PMN P-99-1288) is subject to reporting under this section for the significant new use described in paragraph (a)(1) of this section. (2) The significant new uses are: (i

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as hydrazine, (2-fluorophenyl) (PMN P-95-2101; CAS No. 2368-80-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are:

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as substituted naphthalene hydrazide (PMN P-01-69) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section. (2) The significant new uses are: (i

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as an aliphatic polyisocyanate homopolymer (PMN P-96-1239) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are:

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a hydrochlorofluorocarbon (PMN P-95-1317) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i)

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a hydrochlorofluorocarbon (PMN P-94-1453) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a hydrofluoroalkane (PMN P-96-1288) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i)

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as dialkylamidoimidazoline (PMN P-94-1864) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i)

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substances identified generically as substituted imines (PMNs P-95-1557/1558) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are: (i

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a substituted azo metal complex dye (PMN P-94-499) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are:

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a diazo substituted carbomonocyclic metal complex (PMN P-94-1039) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are:

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a substituted naphthalenesulfonic acid, alkali salt (PMN P-95-85) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. (2) The significant new uses are:

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a trisodium chloro[(trisubstituted heteromonocycleamino) propylamino]triazinyl aminohydroxyazo naphthalenetrisulfonate (PMN P-94-2177) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.

References in Text This chapter, referred to in text, was in the original "this Act", meaning Pub. L. 93–288, May 22, 1974, 88 Stat. 143. For complete classification of this Act to the Code, see Short Title note set out under section 5121 of this title and Tables.

implications of any requirement added to the Juvenile Justice and Delinquency Prevention Act of 1974 which would mandate the removal of juveniles from adults in all jails and lockups, such report to include an estimate of the costs likely to be incurred by the States, an analysis of the experience of States which required the removal of juveniles from adults in all jails and lockups, an analysis of possible adverse ramifications which might result from such requirement of removal, and recommendations for

1980—Pub. L. 96–294 substituted "Secretary" for "Administrator".

Pub. L. 106–398, §1 [div. C, title XXXI, §3156], Oct. 30, 2000, 114 Stat. 1654, 1654A–467, which was formerly set out as a note under this section, was renumbered section 4832 of Pub. L. 107–314, the Bob Stump National Defense Authorization Act for Fiscal Year 2003, by Pub. L. 108–136, div. C, title XXXI, §3141(k)(12), Nov. 24, 2003, 117 Stat. 1785, and is classified to

, 92 Stat. 3289, known as the Powerplant and Industrial Fuel Use Act of 1978, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 8301 of this title and Tables.

overriding national need to provide incentive and protection for physicians engaging in effective professional peer review. Short Title Pub. L. 99–660, title IV, §401, Nov. 14, 1986, 100 Stat. 3784, provided that: "This title [enacting this chapter and provisions set out as a note under

, through its National Research Council, to develop a research agenda based on the recommendations contained in the report entitled "Understanding Violence Against Women" of the National Academy of Sciences and, in consultation with the Secretary of the Department of Health and Human Services, to submit a report to Congress not later than Oct. 28, 2000, which was to include a description of the research agenda, a plan to implement the agenda, and recommendations for priorities in carrying out the agenda

References in Text This chapter, referred to in text, was in the original "this Act", meaning Pub. L. 106–279, Oct. 6, 2000, 114 Stat. 825, known as the Intercountry Adoption Act of 2000, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under

Short Title For short title of title VIII of Pub. L. 109–58, which enacted this subchapter, as the "Spark M. Matsunaga Hydrogen Act of 2005", see section 801 of Pub. L. 109–58, set out as a note under

40310 42 U.S.C. 2486k. Pub. L. 100–147, title II, §213, Oct. 30, 1987, 101 Stat. 875. The date "October 30, 1987" is substituted for "the date of enactment of this Act" to reflect the date of enactment of the National Space Grant College and Fellowship Act, which is title II of the

42 U.S.C. 2464. Pub. L. 97–324, title I, §106(a), Oct. 15, 1982, 96 Stat. 1600. Amendments 2015—Pub. L. 114–90 substituted "space launch system" for "space shuttle" in

conducted in a manner consistent with the protection of information provided to or developed for or by the Commission as required by any applicable statute, regulation, or Executive order. Open Table Historical and Revision Notes

(a) Oral argument before the Judge. Oral argument before the Judge shall be in the discretion of the Judge. Such argument, when permitted, may be limited by the Judge to any extent that the Judge finds necessary for the expeditious disposition of the proceeding and shall be made part of the transcript. (b) Briefs, proposed findings, and conclusions.

The Inspector General shall: (a) Issue directives conforming to this part governing the exercise of the authorities granted by this part. These directives should contain the policies and procedures by which the authorities will be exercised by designated officials of the Office of Inspector General; (b) Establish criteria for qualification by officials of the Office of Inspector General who are

(a) This part specifies the eligibility requirements and payment calculations for the Coronavirus Food Assistance Program (CFAP). CFAP will provide payments with respect to commodities that have been significantly impacted by the effects of the COVID-19 outbreak. Payments will be made with respect to only commodities produced in the United States; commodities imported into the United States may not be used to determine any payment made under this part.

as it can be handled and processed by the buyers' facilities. However, the tobacco ready for marketing during most weeks of the marketing season substantially exceeds the quantities which can be purchased, handled and processed by the currently existing facilities of the buyers. Moreover, the total number of flue-cured markets are substantially greater than the number of sets of buyers assigned by the buying companies or the number of sets of available inspectors. In this situation, about 6

(a) Resident grading basis. Certificates will be issued only upon request therefor by the applicant or the AMS. When requested, a grader shall issue a certificate covering product graded by such grader. In addition, a grader may issue a grading certificate covering product graded in whole or in part by another grader when the grader has knowledge that the product is eligible for certification based on personal examination of the